The Marine Dinoflagellate Alexandrium minutum Activates a Mitophagic Pathway in Human Lung Cancer Cells

Mar Drugs. 2018 Dec 12;16(12):502. doi: 10.3390/md16120502.

Abstract

Marine dinoflagellates are a valuable source of bioactive molecules. Many species produce cytotoxic compounds and some of these compounds have also been investigated for their anticancer potential. Here, we report the first investigation of the toxic dinoflagellate Alexandrium minutum as source of water-soluble compounds with antiproliferative activity against human lung cancer cells. A multi-step enrichment of the phenol⁻water extract yielded a bioactive fraction with specific antiproliferative effect (IC50 = 0.4 µg·mL-1) against the human lung adenocarcinoma cells (A549 cell line). Preliminary characterization of this material suggested the presence of glycoprotein with molecular weight above 20 kDa. Interestingly, this fraction did not exhibit any cytotoxicity against human normal lung fibroblasts (WI38). Differential gene expression analysis in A549 cancer cells suggested that the active fraction induces specific cell death, triggered by mitochondrial autophagy (mitophagy). In agreement with the cell viability results, gene expression data also showed that no mitophagic event was activated in normal cells WI38.

Keywords: Alexandrium minutum; glycoprotein; marine antiproliferative compounds; mitophagy.

MeSH terms

  • A549 Cells
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Apoptosis / drug effects
  • Aquatic Organisms / chemistry*
  • Cell Survival / drug effects
  • Dinoflagellida / chemistry*
  • Drug Screening Assays, Antitumor
  • Humans
  • Lung Neoplasms / drug therapy
  • Marine Toxins / isolation & purification
  • Marine Toxins / pharmacology*
  • Marine Toxins / therapeutic use
  • Mitophagy / drug effects*

Substances

  • Antineoplastic Agents
  • Marine Toxins